Search

Your search keyword '"Corticosteroids -- Laws, regulations and rules"' showing total 49 results
Start Over Descriptor "Corticosteroids -- Laws, regulations and rules"
49 results on '"Corticosteroids -- Laws, regulations and rules"'

1. Studies from Weizmann Institute of Science Have Provided New Information about Adrenal Cortex Hormones (Glucocorticoid-sensitive Period of Corticotroph Development-implications for Mechanisms of Early Life Stress)

Subjects
Laws, regulations and rules, Government regulation, Corticotropin -- Laws, regulations and rules, Glucocorticoids -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, ACTH -- Laws, regulations and rules
Abstract

2024 NOV 5 (NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- Investigators publish new report on Hormones - Adrenal Cortex Hormones. According to news reporting [...]

Published
2024

3. SAN PEDRO CLAVER HOSPITAL invites tenders for 8. Acquisition of Medication (Losartan, Prednisone and Liquid Petroleum Jelly) for Hospital Use for the San Pedro Claver Hospital with Law 1152 (S.U.S.)

Subjects
Corticosteroids -- Laws, regulations and rules, Government regulation, Company acquisition/merger, News, opinion and commentary
Abstract

SAN PEDRO CLAVER HOSPITAL, Bolivia has invited tenders for 8. Acquisition of Medication (Losartan, Prednisone and Liquid Petroleum Jelly) for Hospital Use for the San Pedro Claver Hospital with Law [...]

Published
2024

4. Circadian regulation of hippocampal function is disrupted with chronic corticosteroid treatment

Subjects
Laws, regulations and rules, Government regulation, Physical fitness -- Laws, regulations and rules, Nervous system diseases -- Laws, regulations and rules, Glucocorticoids -- Laws, regulations and rules, Corticosteroid drugs -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules
Abstract

2022 JUL 30 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- According to news reporting based on a preprint abstract, our journalists obtained [...]

Published
2022

5. Open House Drug Discount Agreements Formoterol And Beclometasone, Atc R03ak08

Subjects
Corticosteroids -- Laws, regulations and rules, Government regulation, Contract agreement, Business, international
Abstract

Tenders are invited for open house drug discount agreements formoterol and beclometasone, atc r03ak08 It is not an open procedure, but rather a so-called open-house model! the form for the [...]

Published
2023

6. Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Formoterol + Beclometasone (exclusively Dafo. Dos), Atc R03ak08 For The Period January 1st, 2024 - December 31st, 2025

Subjects
Corticosteroids -- Laws, regulations and rules, Government regulation, Business, international
Abstract

Tenders are invited for conclusion of a non-exclusive discount agreement in accordance with section 130a paragraph 8 sgb v for the active ingredient formoterol + beclometasone (exclusively dafo. dos), atc [...]

Published
2023

7. Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph 8 Sgb V For The Active Ingredient Formoterol + Beclometasone (exclusively Dafo. Ihp, Inh), Atc R03ak08 For The Period January 1st, 2024 - December 31st, 2025

Subjects
Corticosteroids -- Laws, regulations and rules, Government regulation, Business, international
Abstract

Tenders are invited for conclusion of a non-exclusive discount agreement in accordance with section 130a paragraph 8 sgb v for the active ingredient formoterol + beclometasone (exclusively dafo. ihp, inh), [...]

Published
2023

8. Conclusion Of A Non-exclusive Discount Agreement In Accordance With Section 130a Paragraph. 8 Sgb V On The Active Ingredient Formoterol, Beclometasone, Glycopyrronium, Atc R03al09 For The Period November 1st, 2023 - October 31st, 2025

Subjects
Corticosteroids -- Laws, regulations and rules, Government regulation, Business, international
Abstract

Contract notice: Conclusion of a non-exclusive discount agreement in accordance with Section 130a paragraph. 8 sgb v on the active ingredient formoterol, beclometasone, glycopyrronium, atc r03al09 for the period November [...]

Published
2023

9. Open House Drug Discount Agreements Imidazole|triazole In Combination With Corticosteroids, Atc D01ac20

Subjects
Corticosteroids -- Laws, regulations and rules, Triazoles -- Laws, regulations and rules, Government regulation, Contract agreement, Business, international
Abstract

Contract notice: open house drug discount agreements imidazole/triazole in combination with corticosteroids, atc d01ac20 See description of procurementthis is not an open procedure, but rather a so-called open-house model! the [...]

Published
2023

10. Open House Drug Discount Agreements Formoterol, Glycopyrronium Bromide And Beclometasone, Atc R03al09

Subjects
Corticosteroids -- Laws, regulations and rules, Glycopyrrolate -- Laws, regulations and rules, Government regulation, Contract agreement, Business, international
Abstract

Contract notice: open house drug discount agreements formoterol, glycopyrronium bromide and beclometasone, atc r03al09 See description of procurementit is not an open procedure, but a so-called open-house model! the form [...]

Published
2023

11. New Atherosclerosis Data Have Been Reported by Researchers at University of Edinburgh (Glucocorticoids: Fuelling the Fire of Atherosclerosis or Therapeutic Extinguishers?)

Subjects
University of Edinburgh, Laws, regulations and rules, Government regulation, Adrenocortical hormones -- Laws, regulations and rules, Atherosclerosis -- Laws, regulations and rules, Physical fitness -- Laws, regulations and rules, Glucocorticoids -- Laws, regulations and rules, Cardiovascular diseases -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules
Abstract

2021 AUG 14 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- A new study on atherosclerosis is now available. According to news reporting [...]

Published
2021

12. Salimetrics Launches + Stress Add-on for At-Home Sleep Testing

Subjects
Corticosteroids -- Laws, regulations and rules, Sleep disorders -- Laws, regulations and rules, Stress (Psychology) -- Laws, regulations and rules, Sleep -- Laws, regulations and rules, Government regulation, Business, News, opinion and commentary
Abstract

With the new Circadian Phase Sleep + Stress Assessment, individuals can now add salivary cortisol to receive a more comprehensive evaluation of their circadian rhythm. Individuals can easily complete the [...]

Published
2023

13. Reports Summarize Pediatrics Findings from Department of Psychology (Meta-analysis of Associations Between Childhood Adversity and Diurnal Cortisol Regulation)

Subjects
Laws, regulations and rules, Government regulation, Pediatrics -- Laws, regulations and rules, Glucocorticoids -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules
Abstract

2023 JUL 21 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators discuss new findings in Pediatrics. According to news originating from Stony Brook, [...]

Published
2023

14. Conclusion Of A Non-exclusive Discount Agreement According To 130a Para. 8 Sgb V On The Active Ingredient Triamcinolone Acetonide, Atc D07ab09 For The Period 02|01|2023 - 01|31|2025

Subjects
Triamcinolone -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, Government regulation, Business, international
Abstract

Contract notice: Conclusion of a non-exclusive discount agreement according to 130a para. 8 sgb v on the active ingredient triamcinolone acetonide, atc d07ab09 for the period 02/01/2023 - 01/31/2025 130a [...]

Published
2022

15. FTC APPROVES FINAL ORDER REQUIRING GENERIC DRUG MARKETERS ANI PHARMACEUTICALS, INC. AND NOVITIUM PHARMA LLC TO DIVEST RIGHTS AND ASSETS TO GENERIC SULFAMETHOXAZOLE-TRIMETHOPRIM ORAL SUSPENSION AND GENERIC DEXAMETHASONE TABLETS

Subjects
United States. Federal Trade Commission -- Laws, regulations and rules, Antitrust law, Corticosteroids -- Laws, regulations and rules, Generic drugs -- Laws, regulations and rules, Antibacterial agents -- Laws, regulations and rules, Marketing -- Laws, regulations and rules, Oral medication -- Laws, regulations and rules, Government regulation, Antitrust issue, News, opinion and commentary
Abstract

WASHINGTON -- The following information was released by the Federal Trade Commission: Following a public comment period, the Federal Trade Commission has approved a final order settling charges that ANI [...]

Published
2022

16. The Effects of Maltreatment and Neuroendocrine Regulation on Memory Performance

Author

Cicchetti, Dante, Rogosch, Fred A., Howe, Mark L., and Toth, Sheree L.

Subjects
Memory -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, Child development -- Laws, regulations and rules, Child abuse -- Laws, regulations and rules, Government regulation, Health, Psychology and mental health
Abstract

To authenticate to the full-text of this article, please visit this link: http://dx.doi.org/10.1111/j.1467-8624.2010.01488.x Byline: Dante Cicchetti (1), Fred A. Rogosch (2), Mark L. Howe (3), Sheree L. Toth (4) Abstract: This investigation examined basic memory processes, cortisol, and dissociation in maltreated children. School-aged children (age range = 6-13), 143 maltreated and 174 nonmaltreated, were administered the California Verbal Learning Test-Children (D. C. Delis, J. H. Kramer, E. Kaplan, & B. A. Ober, 1994) in a week-long camp setting, daily morning cortisol levels were assessed throughout the duration of camp, and behavioral symptoms were evaluated. Maltreatment and cortisol regulation were not related to short- or long-delay recall or recognition memory. However, children experiencing neglect and/or emotional maltreatment and low cortisol evinced heightened false recognition memory. Dissociative symptoms were higher in maltreated children; however, high dissociation was related to recognition inaccuracy only among nonmaltreated children. Results highlight the interplay between maltreatment and hypocortisolism in children's recognition memory errors. Author Affiliation: (1)University of Minnesota (2)University of Rochester (3)Lancaster University (4)University of Rochester Article note: Correspondence concerning this article should be addressed to Dante Cicchetti, Institute of Child Development, University of Minnesota, 51 East River Road, Minneapolis, MN 55455. Electronic mail may be sent to cicchett@umn.edu.

Published
2010

17. Conclusion Of A Non-exclusive Discount Agreement According To 130a Para. 8 Sgb V On The Active Ingredient Calcipotriol + Betamethasone (gel Dosage Form Only), Atc D05ax22, F. D. Z. 01.02.2022-31.01.2024

Subjects
Health insurance industry -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, Betamethasone -- Laws, regulations and rules, Government regulation, Business, international
Abstract

Contract notice: conclusion of a non-exclusive discount agreement according to 130a para. 8 sgb v on the active ingredient calcipotriol + betamethasone (gel dosage form only), atc d05ax22, f. d. [...]

Published
2021

18. Temporal dynamics of nutrition, parasitism, and stress in colobus monkeys: implications for population regulation and conservation

Author

Chapman, Colin A., Saj, Tania L., and Snaith, Tamaini V.

Subjects
Monkeys -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, Government regulation, Knowledge-based system, Anthropology/archeology/folklore
Abstract

The need to develop conservation plans calls for the ability to identify ecological factors that influence population density. Because stress is known to affect fecundity and mortality, increasing stress may provide a warning of potential population declines. We examined the effects of temporal variation in nutrition and parasitism on stress in endangered red colobus monkeys in Kibale National Park, Uganda. First, we tested the hypothesis that parasitism and nutrition would individually affect stress levels. We found that periods of poor-quality diet corresponded with an increase in cortisol. Similarly, increases in parasite infections were associated with increased cortisol. Next, we predicted that a poor-quality diet would facilitate increased parasite infections, and that together, they would lead to amplified stress. However, we found no support for such amplification, likely because the quality of the diet had little effect on parasite infections. Third, we tested whether individuals in a larger group were subject to food stress due to greater within-group competition, which would intensify nutritional stress and parasitism, and lead to reduced reproduction. Although we found no evidence to support a group size effect on parasites, cortisol levels in the large group tended to be higher than those in the small group, and the large group had fewer infants per female. The results suggest that parasitism and poor nutrition lead to increased stress which, because they are known to be associated with reduced fecundity and increased mortality, may lead to population declines. Am J Phys Anthropol 134:240-250, 2007. KEY WORDS population regulation; primate conservation; parasitism; cortisol; colobus; Kibale national park, within-group competition

Published
2007

19. Glucocorticoid-sensitive period of corticotroph development -- implications in early life stress

Subjects
Laws, regulations and rules, Government regulation, Adrenocortical hormones -- Laws, regulations and rules, Corticotropin -- Laws, regulations and rules, Glucocorticoids -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, ACTH -- Laws, regulations and rules
Abstract

2022 JUN 28 (NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- According to news reporting based on a preprint abstract, our journalists obtained the following [...]

Published
2022

20. Researchers' Work from University of Guelph Focuses on Endocrinology (Neuroendocrine Regulation of Plasma Cortisol Levels During Smoltification and Seawater Acclimation of Atlantic Salmon)

Subjects
University of Guelph -- Evaluation, Evaluation, Laws, regulations and rules, Government regulation, Seawater -- Laws, regulations and rules, Glucocorticoids -- Laws, regulations and rules, Salmon -- Evaluation, Corticosteroids -- Laws, regulations and rules, Sea-water -- Laws, regulations and rules
Abstract

2022 MAY 13 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Fresh data on endocrinology are presented in a new report. According to news [...]

Published
2022

21. Firms fined 260mln over 10,000% rise in price of NHS drugs

Subjects
United Kingdom. Competition and Markets Authority -- Laws, regulations and rules, CINVen -- Laws, regulations and rules, Allergan PLC -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, Drugs -- Laws, regulations and rules, Venture capital companies -- Laws, regulations and rules, Pharmaceutical industry -- Laws, regulations and rules, Government regulation, Business, international, Law
Abstract

A group of companies including Irish drug giant Allergan PLC (NYSE:AGN) and private equity group Cinven have been fined more than 260mln for competition law breaches related to the sale [...]

Published
2021

22. Completion Of A Non-excl. Discount Agreement In Accordance With Section 130a (8) Sgb V For The Active Ingredient Combination Formoterol, Beclometasone, Atc Code: R03ak08 For The Period From 1.8.2021 To 31.7.2023

Subjects
Corticosteroids -- Laws, regulations and rules, Government regulation, Business, international
Abstract

Contract notice: Completion of a non-excl. Discount agreement in accordance with Section 130a (8) SGB V for the active ingredient combination formoterol, beclometasone This announcement serves to conclude drug discount [...]

Published
2021

23. Open House Drug Discount Agreements Betamethasone And Fusidic Acid, Atc D07cc01

Subjects
Corticosteroids -- Laws, regulations and rules, Betamethasone -- Laws, regulations and rules, Government regulation, Business, international
Abstract

Contract notice: Open house drug discount agreements betamethasone and fusidic acid, Atc d07cc01 It is not an open procedure, but a so-called open-house model! The only reason why the form [...]

Published
2021

24. Findings on COVID-19 Reported by Investigators at University of British Columbia (Emotion Regulation and Diurnal Cortisol: a Longitudinal Study of Early Adolescents)

Subjects
University of British Columbia, Laws, regulations and rules, Government regulation, Coronaviruses -- Laws, regulations and rules, Youth -- Laws, regulations and rules, Mental health -- Laws, regulations and rules, Glucocorticoids -- Laws, regulations and rules, COVID-19 -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, Teenagers -- Laws, regulations and rules
Abstract

2022 JAN 9 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Current study results on Coronavirus - COVID-19 have been published. [...]

Published
2022

25. Janssen's Abiraterone Acetate And Prednisone Combination Therapy Patent Found Invalid

Subjects
Apotex Inc. -- Laws, regulations and rules -- Intellectual property, Janssen Inc. -- Intellectual property -- Laws, regulations and rules, Dr. Reddy's Laboratories Ltd. -- Laws, regulations and rules -- Intellectual property, Corticosteroids -- Laws, regulations and rules, Acetates -- Laws, regulations and rules -- Intellectual property, Prednisone -- Laws, regulations and rules -- Intellectual property, Patent infringement -- Laws, regulations and rules, Pharmaceutical industry -- Intellectual property, Government regulation, Business, international, Zytiga (Medication) -- Intellectual property
Abstract

On January 14, 2020, the Federal Court released a decision by Phelan J. in patent infringement actions pursuant to subsection 6(1) of the Patented Medicines (Notice of Compliance) Regulations (PMNOC [...]

Published
2021

26. Level of postoperative analgesia is a critical factor in regulation of myometrial contractility after laparotomy in the pregnant baboon: Implications for human fetal surgery

Author

Tame, Jennifer D., Abrams, Laura M., Ding, Xiu-Ying, Yen, Andrew, Giussani, Dino A., and Nathanielsz, Peter W.

Subjects
Pregnancy -- Laws, regulations and rules, Estradiol -- Laws, regulations and rules, Dehydroepiandrosterone -- Laws, regulations and rules, Analgesia -- Laws, regulations and rules, Buprenorphine -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, Pregnant women -- Laws, regulations and rules, Primates -- Laws, regulations and rules, Halothane -- Laws, regulations and rules, Pituitary hormones -- Laws, regulations and rules, Sulfates -- Laws, regulations and rules, Government regulation, Health
Abstract

Byline: Jennifer D. Tame, Laura M. Abrams, Xiu-Ying Ding, Andrew Yen, Dino A. Giussani, Peter W. Nathanielsz Keywords: Baboon; estrogen; laparotomy; myometrium; opioid analgesia Abstract: Objectives: We used 2 dosage levels of postoperative opioid administration to determine whether the degree of postoperative analgesia after laparotomy during the last third of baboon pregnancy alters maternal pituitary-adrenal function, androgen secretion, and placental estrogen production. We also determined the relationship of estrogen production to surgery-induced increase in myometrial contraction activity. Study Design: After laparotomy under halothane general anesthesia at 0.75 gestation, 10 pregnant baboons were administered intra-arterially either a normal dose or a double dose of the opioid analgesic buprenorphine for 48 hours. Maternal plasma samples for steroid hormone and oxytocin analyses were obtained at circadian time 1000 hours and at circadian time 1800 hours, 4 hours before and 4 hours after the lights went off, respectively. Myometrial electromyographic contraction activity was quantified for the 6 hours from circadian time 1100 hours to circadian time 1700 hours. Results: Maternal plasma cortisol and dehydroepiandrosterone sulfate concentrations were lower in the dark period (at circadian time 1800 hours) than during daylight (at circadian time 1000 hours) in the double-dose group but not the normal dose group. In contrast, maternal plasma estradiol level was higher at circadian time 1800 hours than at circadian time 1000 hours in the normal dose group but not in the double-dose group. Maternal plasma estrogen level was higher during the hours of darkness in the normal dose group than in the double-dose group. Furthermore the number of myometrial contractions around the onset of darkness was greater in the normal dose group than in the double-dose group. Conclusions: The double dose of analgesia results in lower maternal nighttime plasma estradiol concentrations and significantly less nocturnal contraction activity. These observations further confirm an association between increased maternal plasma estrogen concentrations and increased myometrial contractility in the nonhuman primate. In addition, they suggest that adjustment of the level of postoperative analgesia may be of importance in preventing premature labor after chuman intrauterine fetal surgery. (Am J Obstet Gynecol 1999;180:1196-201.) Author Affiliation: Laboratory for Pregnancy and Newborn Research, Department of Physiology, College of Veterinary Medicine, Cornell University. Ithaca, New York Article History: Received 22 June 1998; Revised 19 October 1998; Accepted 28 January 1999 Article Note: (footnote) [star] Supported by National Institutes of Health, National Institute of Child Health and Human Development grant HD 21350., [star][star] Reprint requests: Peter W. Nathanielsz, MD, PhD, ScD, Laboratory for Pregnancy and Newborn Research, Department of Physiology, Box 16, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853-6401., a 0002-9378/99 $8.00 + 0 6/1/97484

Published
1999

31. FDA Notifies Consumers Not to Use Mayhem: AttorneyOne Monitors and Keeps Consumers Informed

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, Government regulation, Business, general
Abstract

San Diego, CA (PRWEB) November 17, 2014 AttorneyOne.com, a recognized authority on law, update the website daily regarding all the latest information from the FDA on Mayhem. The US FDA [...]

Published
2014

32. FDA Advises Not to Use Ginseng Kianpi Pil: AttorneyOne Monitors and Keeps Consumers Informed

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, Government regulation, Business, general
Abstract

San Diego, CA (PRWEB) November 04, 2014 AttorneyOne.com, a recognized authority on law, updates the website daily regarding all the latest information from the FDA on Ginseng Kianpi Pil. The [...]

Published
2014

33. New Animal Drug Approvals; Change of Sponsor; Change of Sponsor's Drug Labeler Code; Gonadorelin Acetate; Isoflurane; Praziquantel; Propofol; Sevoflurane; Triamcinolone Acetonide

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, Triamcinolone -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, Steroids -- Laws, regulations and rules, Labeling-machines -- Laws, regulations and rules, Antiparasitic agents -- Laws, regulations and rules, Anesthetics -- Laws, regulations and rules, General anesthetics -- Laws, regulations and rules, Veterinary supplies industry -- Laws, regulations and rules, Acetates -- Laws, regulations and rules, Government regulation, Government
Abstract

SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval actions for new animal drug applications (NADAs) and abbreviated new animal drug applications (ANADAs) [...]

Published
2013

34. New Animal Drugs; Change of Sponsor; Change of Sponsor Address; Azaperone; Miconazole, Polymyxin B, and Prednisolone Suspension

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, Janssen Pharmaceutica N.V. -- Laws, regulations and rules, Eli Lilly and Co. -- Laws, regulations and rules, Steroids -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, Prednisolone -- Laws, regulations and rules, Veterinary supplies industry -- Laws, regulations and rules, Miconazole -- Laws, regulations and rules, Pharmaceutical industry -- Laws, regulations and rules, Government regulation, Government
Abstract

SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for two new animal drug applications (NADAs) from Janssen Pharmaceutica NV, [...]

Published
2012

35. New animal drugs; ampicillin trihydrate, bacitracin methylene disalicylate, flunixin, gonadotropin releasing factor analog-diphtheria toxoid conjugate, methylprednisolone, and sulfamethazine

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, Methylprednisolone -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, Biological products -- Laws, regulations and rules, Bacitracin -- Laws, regulations and rules, Ampicillin -- Laws, regulations and rules, Gonadotropin -- Laws, regulations and rules, Veterinary supplies industry -- Laws, regulations and rules, Government regulation, Business, Chemicals, plastics and rubber industries
Abstract

The US Food and Drug Administration (FDA) is amending the animal drug regulations to reflect revised human food safety warnings on dosage form new animal drug product labelling that have [...]

Published
2011

36. New Animal Drugs; Ampicillin Trihydrate, Bacitracin Methylene Disalicylate, Flunixin, Gonadotropin Releasing Factor Analog-Diphtheria Toxoid Conjugate, Methylprednisolone, and Sulfamethazine

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, Methylprednisolone -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, Steroids -- Laws, regulations and rules, Biological products -- Laws, regulations and rules, Ampicillin -- Laws, regulations and rules, Gonadotropin -- Laws, regulations and rules, Veterinary supplies industry -- Laws, regulations and rules, Government regulation, Government
Abstract

SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect revised human food safety warnings on dosage form new animal drug product labeling that have [...]

Published
2011

37. Tolerances for Residues of New Animal Drugs in Food; 2-Acetylamino-5-Nitrothiazole; Buquinolate; Chlorobutanol; Estradiol and Related Esters; Ethylenediamine; Florfenicol; Flunixin; Furazolidone; Hydrocortisone; Methylparaben; Methylprednisolone; Prednisolone; Prednisone; Progesterone; Propylparaben; and Salicylic Acid

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, Estradiol -- Laws, regulations and rules, Food additives industry -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, Esters -- Laws, regulations and rules, Ethylenediamines -- Laws, regulations and rules, Phenols -- Laws, regulations and rules, Progesterone -- Laws, regulations and rules, Fluocinolone acetonide -- Laws, regulations and rules, Veterinary supplies industry -- Laws, regulations and rules, Immunosuppressive agents -- Laws, regulations and rules, Furazolidone -- Laws, regulations and rules, Government regulation, Government
Abstract

SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the revocation of tolerances for residues of various substances in food because approval has been [...]

Published
2011

38. Advisory panels: no go on OTC topical steroids

Author

Ault, Alicia

Subjects
United States. Food and Drug Administration -- Management -- Laws, regulations and rules, Management, Laws, regulations and rules, Government regulation, Company business management, Nonprescription drugs -- Laws, regulations and rules, Corticosteroid drugs -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules
Abstract

GAITHERSBURG, MD. -- Although some manufacturers are seeking Food and Drug Administration approval to sell prescription-strength topical corticosteroids over the counter, it is not likely to happen soon. At a [...]

Published
2005

39. FDA orders labelling changes for steroids

Subjects
United States. Food and Drug Administration -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, Pharmaceutical industry -- Laws, regulations and rules, Labels -- Laws, regulations and rules, Business, Pharmaceuticals and cosmetics industries
Published
1998

40. UK CSM proposes P to POM changes

Subjects
Pharmaceutical industry -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, Business, Pharmaceuticals and cosmetics industries
Published
1998

41. Glucocorticoid regulation enhances therapeutic angiogenesis

Subjects
National Academy of Sciences, Laws, regulations and rules, Government regulation, Heart attack -- Laws, regulations and rules, Steroids (Organic compounds) -- Laws, regulations and rules, Glucocorticoids -- Laws, regulations and rules, Urban planning -- Laws, regulations and rules, Steroids -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, City planning -- Laws, regulations and rules
Abstract

Glucocorticoid regulation enhances therapeutic angiogenesis. 'Angiogenesis restores blood flow to healing tissues, a process that is inhibited by high doses of glucocorticoids. However, the role of endogenous glucocorticoids and the [...]

Published
2005

42. Glucocorticoid regulation enhances therapeutic angiogenesis

Subjects
National Academy of Sciences, Laws, regulations and rules, Government regulation, Heart attack -- Laws, regulations and rules, Steroids (Organic compounds) -- Laws, regulations and rules, Glucocorticoids -- Laws, regulations and rules, Urban planning -- Laws, regulations and rules, Steroids -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, City planning -- Laws, regulations and rules
Abstract

Glucocorticoid regulation enhances therapeutic angiogenesis. 'Angiogenesis restores blood flow to healing tissues, a process that is inhibited by high doses of glucocorticoids. However, the role of endogenous glucocorticoids and the [...]

Published
2005

43. Glucocorticoid regulation enhances therapeutic angiogenesis

Subjects
National Academy of Sciences, Laws, regulations and rules, Government regulation, Heart attack -- Laws, regulations and rules, Steroids (Organic compounds) -- Laws, regulations and rules, Glucocorticoids -- Laws, regulations and rules, Urban planning -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, Steroids -- Laws, regulations and rules, City planning -- Laws, regulations and rules
Abstract

Glucocorticoid regulation enhances therapeutic angiogenesis. 'Angiogenesis restores blood flow to healing tissues, a process that is inhibited by high doses of glucocorticoids. However, the role of endogenous glucocorticoids and the [...]

Published
2005

44. FDA advisers mull requirements for topical corticosteroids OTC switch

Subjects
United States. Food and Drug Administration -- Powers and duties, Pharmaceutical industry -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules, Government regulation, Pharmaceuticals and cosmetics industries
Abstract

Pharmaceutical manufacturers would need to show that their products cause only minimal suppression of the hypothalamic-pituitary-adrenal (HPA) axis if they want to move their prescription topical corticosteroids over-the-counter, said panelists [...]

Published
2005

45. Calcium and sodium regulation supports osteoporosis and hypertension therapies

Subjects
Laws, regulations and rules, Government regulation, Osteoporosis -- Laws, regulations and rules, Hypertension -- Laws, regulations and rules, Heart diseases -- Laws, regulations and rules, Cardiology -- Laws, regulations and rules, Endocrinology -- Laws, regulations and rules, Corticosteroid drugs -- Laws, regulations and rules, Cardiovascular agents -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules
Abstract

2004 JAN 25 - (NewsRx.com & NewsRx.net) -- Calcium and sodium regulation supports osteoporosis and hypertension therapies. 'Hypertension and osteoporosis are characteristic clinical features in patients with Cushing's syndrome or [...]

Published
2004

46. Calcium and sodium regulation supports osteoporosis and hypertension therapies

Subjects
Laws, regulations and rules, Government regulation, Osteoporosis -- Laws, regulations and rules, Hypertension -- Laws, regulations and rules, Endocrinology -- Laws, regulations and rules, Corticosteroid drugs -- Laws, regulations and rules, Cardiovascular agents -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules
Abstract

2004 JAN 23 - (NewsRx.com & NewsRx.net) -- Calcium and sodium regulation supports osteoporosis and hypertension therapies. 'Hypertension and osteoporosis are characteristic clinical features in patients with Cushing's syndrome or [...]

Published
2004

47. Calcium and sodium regulation supports osteoporosis and hypertension therapies

Subjects
Laws, regulations and rules, Government regulation, Osteoporosis -- Laws, regulations and rules, Hypertension -- Laws, regulations and rules, Endocrinology -- Laws, regulations and rules, Corticosteroid drugs -- Laws, regulations and rules, Cardiovascular agents -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules
Abstract

2004 JAN 21 - (NewsRx.com & NewsRx.net) -- Calcium and sodium regulation supports osteoporosis and hypertension therapies. 'Hypertension and osteoporosis are characteristic clinical features in patients with Cushing's syndrome or [...]

Published
2004

48. Calcium and sodium regulation supports osteoporosis and hypertension therapies

Subjects
Laws, regulations and rules, Government regulation, Osteoporosis -- Laws, regulations and rules, Hypertension -- Laws, regulations and rules, Endocrinology -- Laws, regulations and rules, Corticosteroid drugs -- Laws, regulations and rules, Cardiovascular agents -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules
Abstract

2004 JAN 19 - (NewsRx.com & NewsRx.net) -- Calcium and sodium regulation supports osteoporosis and hypertension therapies. 'Hypertension and osteoporosis are characteristic clinical features in patients with Cushing's syndrome or [...]

Published
2004

49. Calcium and sodium regulation supports osteoporosis and hypertension therapies

Subjects
Laws, regulations and rules, Government regulation, Osteoporosis -- Laws, regulations and rules, Hypertension -- Laws, regulations and rules, Endocrinology -- Laws, regulations and rules, Corticosteroid drugs -- Laws, regulations and rules, Cardiovascular agents -- Laws, regulations and rules, Corticosteroids -- Laws, regulations and rules
Abstract

2004 JAN 19 - (NewsRx.com & NewsRx.net) -- Calcium and sodium regulation supports osteoporosis and hypertension therapies. 'Hypertension and osteoporosis are characteristic clinical features in patients with Cushing's syndrome or [...]

Published
2004

Catalog

Books, media, physical & digital resources
See catalog results